中國巨石(600176.SH)擬投建年產6萬噸電子紗暨年產3億米電子布生產線建設方案調整項目
格隆匯3月19日丨中國巨石(600176.SH)公佈,為進一步優化公司產品結構,增強市場競爭力,公司擬對桐鄉智能製造基地細紗三期年產6萬噸電子紗暨年產3億米電子布生產線項目的產能和產品結構進行調整,產能由原來的6萬噸提升至10萬噸,產品結構由2116系列、1080系列和7628系列全部調整為7628系列的電子布。項目建設週期1年,計劃於2021年上半年啟動。項目總投資36.71億元,資金來源為公司自籌及銀行貸款。項目建成後,預計每年可實現銷售收入12.54億元,年平均利潤總額4.58億元(上述數據僅為公司對項目投資收益的預計金額,不構成公司對項目投資收益的承諾)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.